ConductCognition
  • Domains

    Tests

    • Processing speed43
    • Attention113
    • Working memory50
    • Executive function143
    • Episodic memory72
    • Response inhibition9
    • Social cognition75
    • Language42

    Most used

    Evidence

    1. Verbal Fluency TestGradeA
    2. Stroop Color-Word TestGradeA
    3. Trail Making TestGradeA
    4. N-Back TaskGradeA
    5. Go/No-Go TaskGradeA
    6. Digit Span TestGradeA
    7. Symbol Coding TestGradeA
    8. Verbal Learning TestGradeA
    REDTry it nowStroop Color-Word Test
    All 547 tests

    Browse by

    • Phone290
    • Tablet323
    • Untimed326
    • Up to 5 minutes69
    • Evidence grade A40
  • First studies

    Grade, length

    • Reaction Time StudyGradeA7 min
    • Pilot ScreeningGradeA15 min
    • Medication StudiesGradeA−26 min
    • Language-Minimized ScreeningGradeA−30 min

    Age groups

    • Older Adult Executive SpeedGradeA20 min
    • School-AgeGradeA−33 min

    Memory

    • At-Home MemoryGradeA26 min
    • Working Memory and LearningGradeA−19 min
    • Associative MemoryGradeB32 min
    • Working Memory CapacityGradeB34 min

    Language and perception

    • LanguageGradeA−33 min
    • Visual PerceptionGradeB27 min
    • Listening and Auditory ProcessingGradeB31 min

    Executive function and attention

    • Executive ControlGradeA18 min
    • Attention and ImpulsivityGradeA−26 min
    • Visual AttentionGradeB27 min
    • Creativity and Flexible ThinkingGradeB30 min
    • Reasoning and SpatialGradeB32 min

    Movement

    • Motor and AttentionGradeA−29 min
    • Motor LearningGradeB34 min

    Behavior, mood and choice

    • Food Choice and Self-ControlGradeA−29 min
    • Sleep and FatigueGradeB23 min
    • Social CognitionGradeB23 min
    • Impulsivity and Substance UseGradeB26 min
    • Emotion and MoodGradeB28 min
    • Decisions and RewardGradeB29 min
    All 26 batteries

    Find one

    Up to 15 minutes2Up to 30 minutes19Phone8
    Test order labBattery gradesHow batteries work
  • Use and evidence

    • Overview
    • Compare all 547 tests
    • Test-retest
    • Reliability and validity
    • Battery grades26
    • Download and cite

    Clinical trials

    • Overview
    • By condition25
    • By test101
    • Trial design benchmark
    • Cognitive outcomes, 2026

    Conditions

    Registered studies

    • Dementia and Alzheimer's1,673
    • Aging, frailty and exercise1,398
    • Depression and bipolar disorder1,247
    • Stroke1,233
    • Substance use and addiction895
    • Parkinson's disease892
    • Cancer760
    All 25 conditions
    16,361Registered studies name a cognitive test in an outcome measure11,688 name a test you can run hereExplore the studies
  • 1

    Build

    • Study design
    • Customize tests
    • Repeat visits
    • Study cost calculator
    2

    Recruit

    • Recruitment setup
    • Prolific
    • Sona Systems
    • CloudResearch Connect
    • Qualtrics
    3

    Run

    • Remote testing
    • Participant devices
    • Phone timing check
    • Offline edition
    4

    Results

    • Automated scoring
    • Test norms
    • Study Quality Monitor
    • Data export
    Platform overview

    Compliance

    • HIPAA-ready testing
    • US clinical research
    • Data Policy
    • Privacy Policy
    • Terms of Use
  • Research areas

    Tests used in each

    • Aging and dementia188
    • Decisions and reward105
    • Child development and education87
    • Language and bilingualism64
    • Social behavior62
    • Psychiatric groups35
    • Training and intervention28
    • Mood, anxiety and trauma25
    • Substance use and impulsivity25
    • Neurological and movement research19
    • Brain injury and concussion14
    • Sleep and fatigue14
    • ADHD11
    • Eating and obesity8
    • Medication and drug trials8

    Research settings

    • Student participant pools
    • Teaching a class
    • Clinical trials
    • US clinical research
    • Sites without internet
    Planning a study?
  • Methods

    • How evidence grades work
    • How test batteries work
    • How test order works
    Methods and questions

    Help

    • FAQ
    • Recruitment guides
    • Compare platforms

    Updates

    • Blog
    • New tests by email
    Latest post10 November 2026What you can do in ConductCognition todayA short tour of ConductCognition as it stands on 10 November. After this, we'll post when something changes how you run a study.Read the post
  • Pricing
Start Free
Log In
Log InStart Free
  1. Home
  2. /Data
  3. /Clinical trials
  4. /Tests
  5. /Psychomotor Vigilance Task

Clinical trials data

Psychomotor Vigilance Task in clinical trials: 395 registered studies

Every registered study on ClinicalTrials.gov that names the Psychomotor Vigilance Task in an outcome measure: the conditions it is used in, how often it is a primary outcome, the tests it is named with, and how large the studies are.

Registered studies name it in an outcome measure
395
Name it in a primary outcome, 39%
154 of 395
Against similar tests
Of studies started 2021 to 2025 name it, against 2.3% in 2016 to 2020
2.2%
By year
Median participants per study
52
By phase
Try the Psychomotor Vigilance Task

The conditions it is used in

Each study counted once in each condition group it falls in.
  1. Sleep and sleep disorders237 studies, 89 as a primary outcome

  2. Pain and fatigue35 studies, 17 as a primary outcome

  3. Healthy volunteers31 studies, 11 as a primary outcome

  4. Substance use and addiction20 studies, 6 as a primary outcome

  5. Depression and bipolar disorder18 studies, 4 as a primary outcome

  6. Obesity and diabetes16 studies, 2 as a primary outcome

  7. Aging, frailty and exercise13 studies, 5 as a primary outcome

  8. Anxiety, PTSD and OCD12 studies, 3 as a primary outcome

  9. Parkinson's disease10 studies, 2 as a primary outcome

  10. Cardiovascular disease10 studies, 2 as a primary outcome

  11. Lung disease10 studies, 1 as a primary outcome

  12. Dementia and Alzheimer's7 studies, 3 as a primary outcome

  13. Mild cognitive impairment7 studies, 3 as a primary outcome

  14. Cancer5 studies, 1 as a primary outcome

  15. Delirium, surgery and intensive care5 studies, 2 as a primary outcome

  16. Epilepsy5 studies, 2 as a primary outcome

  17. Stroke4 studies, 0 as a primary outcome

  18. Brain injury and concussion4 studies, 3 as a primary outcome

  19. COVID-19 and long COVID3 studies, 2 as a primary outcome

  20. Multiple sclerosis2 studies, 1 as a primary outcome

  21. ADHD2 studies, 0 as a primary outcome

  22. Cognitive impairment and decline2 studies, 1 as a primary outcome

  23. Schizophrenia and psychosis1 study, 0 as a primary outcome

  24. Huntington's disease1 study, 0 as a primary outcome

  25. Other conditions49 studies, 23 as a primary outcome

A test as a primary outcomeOnly in secondary or other outcomes

How often it is a primary outcome

The Psychomotor Vigilance Task is a primary outcome in 39% of its studies. Across the 18 attention tests with a page here, the median is 41%.
  1. Eriksen Flanker Task53% of 334 studies

  2. Oddball Target Detection47% of 86 studies

  3. Sustained Attention to Response46% of 85 studies

  4. Dot-Probe Task43% of 148 studies

  5. Rapid Visual Information Processing42% of 204 studies

  6. Continuous Performance Test42% of 638 studies

  7. Attention Network Test41% of 138 studies

  8. Choice Reaction Time40% of 270 studies

  9. Cancellation Test40% of 253 studies

  10. Psychomotor Vigilance Task39% of 395 studies

  11. Contrast Sensitivity Test35% of 119 studies

  12. Line Angle Matching30% of 69 studies

Studies by start year

2.2% of the registered studies that started in 2021 to 2025 name it, against 2.3% of those that started in 2016 to 2020. 2026 is partly planned starts.
02000: 0 studies, 0 with a test as a primary outcome20002001: 0 studies, 0 with a test as a primary outcome2002: 1 studies, 0 with a test as a primary outcome2003: 3 studies, 0 with a test as a primary outcome2004: 1 studies, 0 with a test as a primary outcome2005: 3 studies, 2 with a test as a primary outcome20052006: 7 studies, 4 with a test as a primary outcome2007: 5 studies, 1 with a test as a primary outcome2008: 4 studies, 1 with a test as a primary outcome2009: 2 studies, 1 with a test as a primary outcome2010: 9 studies, 5 with a test as a primary outcome20102011: 5 studies, 2 with a test as a primary outcome2012: 6 studies, 4 with a test as a primary outcome2013: 11 studies, 5 with a test as a primary outcome2014: 12 studies, 5 with a test as a primary outcome2015: 12 studies, 4 with a test as a primary outcome20152016: 21 studies, 10 with a test as a primary outcome2017: 15 studies, 7 with a test as a primary outcome2018: 21 studies, 9 with a test as a primary outcome2019: 25 studies, 11 with a test as a primary outcome2020: 21 studies, 9 with a test as a primary outcome20202021: 32 studies, 14 with a test as a primary outcome2022: 31 studies, 9 with a test as a primary outcome2023: 29 studies, 11 with a test as a primary outcome2024: 32 studies, 9 with a test as a primary outcome2025: 33 studies, 10 with a test as a primary outcome20252026: 53 studies, 20 with a test as a primary outcome

A test as a primary outcomeOnly in secondary or other outcomes

Show as a table
Registered studies by start year
Start yearStudiesA test as a primary outcome
200000
200100
200210
200330
200410
200532
200674
200751
200841
200921
201095
201152
201264
2013115
2014125
2015124
20162110
2017157
2018219
20192511
2020219
20213214
2022319
20232911
2024329
20253310
20265320

Phases and study sizes

By phase

  • Early phase 17 studies, 5 as a primary outcome
  • Phase 113 studies, 5 as a primary outcome
  • Phase 1/27 studies, 2 as a primary outcome
  • Phase 234 studies, 5 as a primary outcome
  • Phase 2/32 studies, 0 as a primary outcome
  • Phase 313 studies, 2 as a primary outcome
  • Phase 419 studies, 8 as a primary outcome
  • Not applicable264 studies, 105 as a primary outcome
  • Observational36 studies, 22 as a primary outcome

Participants per study

102050100200
  • Phase 142 median, 17 to 80
  • Phase 261 median, 35 to 139
  • Phase 3150 median, 105 to 176
  • Phase 446 median, 32 to 86
  • Not applicable48 median, 25 to 89
  • Observational100 median, 55 to 172
Participants per study. The bar spans the middle half of the studies in each phase, the mark is the median, and the axis is logarithmic. Phases with fewer than 10 studies that give a size are left out.
Show as a table
Participants per study that names the Psychomotor Vigilance Task, by phase
PhaseStudies with a sizeMedianMiddle half
Phase 1134217 to 80
Phase 2346135 to 139
Phase 313150105 to 176
Phase 4184632 to 86
Not applicable2604825 to 89
Observational3510055 to 172

When trials measure it

Half of the primary outcomes that name the Psychomotor Vigilance Task are measured within 2 weeks of the start, and the middle half from the first day to 6 weeks. 131 primary outcomes give a duration.

Latest time point of each outcome

  • Within a day87 outcomes, 42 as a primary outcome
  • Up to 4 weeks123 outcomes, 49 as a primary outcome
  • 1 to 3 months77 outcomes, 24 as a primary outcome
  • 3 to 6 months22 outcomes, 2 as a primary outcome
  • 6 to 12 months13 outcomes, 5 as a primary outcome
  • 1 to 2 years9 outcomes, 6 as a primary outcome
  • Over 2 years4 outcomes, 3 as a primary outcome
  • No duration given60 outcomes, 23 as a primary outcome

A test as a primary outcomeOnly in secondary or other outcomes

335 of the 395 outcome measures give a duration. A single visit counts as within a day.

Status, results, interventions and countries

Status

  • Recruiting86 studies, 19 as a primary outcome
  • Not yet recruiting22 studies, 12 as a primary outcome
  • Active, not recruiting13 studies, 6 as a primary outcome
  • Completed225 studies, 94 as a primary outcome
  • Stopped early19 studies, 11 as a primary outcome
  • Status unknown30 studies, 12 as a primary outcome

What they test

  • Behavioral108 studies, 42 as a primary outcome
  • Drug110 studies, 31 as a primary outcome
  • Device93 studies, 31 as a primary outcome
  • Dietary supplement26 studies, 16 as a primary outcome
  • Procedure10 studies, 3 as a primary outcome
  • Diagnostic test5 studies, 2 as a primary outcome
  • Biological2 studies, 1 as a primary outcome
  • Radiation4 studies, 2 as a primary outcome
  • Combination product2 studies, 0 as a primary outcome
  • Other102 studies, 42 as a primary outcome
  • None given10 studies, 7 as a primary outcome

Intervention types as registered. A study can list several; observational studies often list none.

Where their sites are

  • United States211 studies, 85 as a primary outcome
  • Switzerland31 studies, 5 as a primary outcome
  • France23 studies, 7 as a primary outcome
  • Germany14 studies, 2 as a primary outcome
  • Netherlands13 studies, 0 as a primary outcome
  • Canada12 studies, 3 as a primary outcome
  • Singapore12 studies, 9 as a primary outcome
  • Australia10 studies, 0 as a primary outcome
  • China9 studies, 1 as a primary outcome
  • Italy9 studies, 3 as a primary outcome
  • Spain9 studies, 2 as a primary outcome
  • Taiwan9 studies, 2 as a primary outcome

40 countries in all. A study with sites in several counts in each; 17 list no site.

Reported results

Completed studies with results posted on ClinicalTrials.gov, a results paper the registry links to the study, or both.

Completed studies that name the Psychomotor Vigilance Task: 123 of 225, 55%

Every completed study with a cognitive outcome: 3,626 of 7,953, 46%

Completed studies that name the Psychomotor Vigilance Task and every completed study, by how they reported results
ResultsCompleted studies that name the Psychomotor Vigilance TaskEvery completed study
Results on ClinicalTrials.gov and a paper25, 11%776, 10%
Results on ClinicalTrials.gov only29, 13%1,139, 14%
A results paper only69, 31%1,711, 22%
Neither102, 45%4,327, 54%

Tests named in the same studies

The library tests that studies naming the Psychomotor Vigilance Task name most often beside it.
  1. 1

    Symbol Coding52 studies, 21 as a primary outcome

  2. 2

    N-Back Task46 studies, 22 as a primary outcome

  3. 3

    Stroop Color-Word Test34 studies, 13 as a primary outcome

  4. 4

    Trail Making Test22 studies, 7 as a primary outcome

  5. 5

    Go/No-Go Task20 studies, 8 as a primary outcome

  6. 6

    Digit Span Test18 studies, 6 as a primary outcome

  7. 7

    Verbal Learning17 studies, 5 as a primary outcome

  8. 8

    Balloon Risk16 studies, 8 as a primary outcome

  9. 9

    Simple Reaction Time13 studies, 5 as a primary outcome

  10. 10

    Eriksen Flanker Task12 studies, 8 as a primary outcome

A test as a primary outcomeOnly in secondary or other outcomes

Compared over time

Studies per start year for the Psychomotor Vigilance Task and the tests named with it most. Add or remove tests to compare.
Psychomotor Vigilance Task394 studies, 2000 to 2026
01002002000201020202026
Symbol Coding1,448 studies, 2000 to 2026
01002002000201020202026
N-Back Task787 studies, 2000 to 2026
01002002000201020202026
Stroop Color-Word Test1,922 studies, 2000 to 2026
01002002000201020202026

The panel's testThe other tests chosenEvery panel has the same scale. 2026 is partly planned starts.

Show as a table
Registered studies per start year that name each test
Start yearPsychomotor Vigilance TaskSymbol CodingN-Back TaskStroop Color-Word Test
20000103
20010203
20021325
20033322
200411108
200537411
20067836
20075141013
20084141015
2009218516
20109281129
20115302031
20126271432
201311352342
201412472564
201512392567
201621723285
201715715179
2018218354103
2019259459119
202021793099
20213211670151
20223110762168
20232914071198
20243213469182
20253313467198
20265313168193

Explore the 395 studies

Filter by condition, phase, sponsor, status, country, intervention, outcome list, size and start year. Each study links to its record on ClinicalTrials.gov.
TestThe Psychomotor Vigilance Task

395 studies match. 154 name the Psychomotor Vigilance Task in a primary outcome. Median size 52 participants. Median time to the primary outcome: 2 weeks.

Loading 395 studies; the filters turn on when they arrive.

By start year
02040602000: 0 studies, 0 naming the Psychomotor Vigilance Task in a primary outcome20002001: 0 studies, 0 naming the Psychomotor Vigilance Task in a primary outcome2002: 1 studies, 0 naming the Psychomotor Vigilance Task in a primary outcome2003: 3 studies, 0 naming the Psychomotor Vigilance Task in a primary outcome2004: 1 studies, 0 naming the Psychomotor Vigilance Task in a primary outcome2005: 3 studies, 2 naming the Psychomotor Vigilance Task in a primary outcome20052006: 7 studies, 4 naming the Psychomotor Vigilance Task in a primary outcome2007: 5 studies, 1 naming the Psychomotor Vigilance Task in a primary outcome2008: 4 studies, 1 naming the Psychomotor Vigilance Task in a primary outcome2009: 2 studies, 1 naming the Psychomotor Vigilance Task in a primary outcome2010: 9 studies, 5 naming the Psychomotor Vigilance Task in a primary outcome20102011: 5 studies, 2 naming the Psychomotor Vigilance Task in a primary outcome2012: 6 studies, 4 naming the Psychomotor Vigilance Task in a primary outcome2013: 11 studies, 5 naming the Psychomotor Vigilance Task in a primary outcome2014: 12 studies, 5 naming the Psychomotor Vigilance Task in a primary outcome2015: 12 studies, 4 naming the Psychomotor Vigilance Task in a primary outcome20152016: 21 studies, 10 naming the Psychomotor Vigilance Task in a primary outcome2017: 15 studies, 7 naming the Psychomotor Vigilance Task in a primary outcome2018: 21 studies, 9 naming the Psychomotor Vigilance Task in a primary outcome2019: 25 studies, 11 naming the Psychomotor Vigilance Task in a primary outcome2020: 21 studies, 9 naming the Psychomotor Vigilance Task in a primary outcome20202021: 32 studies, 14 naming the Psychomotor Vigilance Task in a primary outcome2022: 31 studies, 9 naming the Psychomotor Vigilance Task in a primary outcome2023: 29 studies, 11 naming the Psychomotor Vigilance Task in a primary outcome2024: 32 studies, 9 naming the Psychomotor Vigilance Task in a primary outcome2025: 33 studies, 10 naming the Psychomotor Vigilance Task in a primary outcome20252026: 53 studies, 20 naming the Psychomotor Vigilance Task in a primary outcome

2026 is partly planned starts. Not shown: 1 planned to start after 2026.

Show as a table
Matching studies by start year
Start yearStudiesAs a primary outcome
200000
200100
200210
200330
200410
200532
200674
200751
200841
200921
201095
201152
201264
2013115
2014125
2015124
20162110
2017157
2018219
20192511
2020219
20213214
2022319
20232911
2024329
20253310
20265320

Library tests named most

  • Psychomotor Vigilance Task395 studies, 154 as a primary outcome
  • Symbol Coding52 studies, 21 as a primary outcome
  • N-Back Task46 studies, 22 as a primary outcome
  • Stroop Color-Word Test34 studies, 13 as a primary outcome
  • Trail Making Test22 studies, 7 as a primary outcome
  • Go/No-Go Task20 studies, 8 as a primary outcome
  • Digit Span Test18 studies, 6 as a primary outcome
  • Verbal Learning17 studies, 5 as a primary outcome
  • Balloon Risk16 studies, 8 as a primary outcome
  • Simple Reaction Time13 studies, 5 as a primary outcome

Largest condition groups

Phases

Participants

Lead sponsor: industry 48, NIH 1, other 346. Interventional 359, observational 36.

As a primary outcomeSecondary or other outcomeThe Psychomotor Vigilance Task

The studies, newest registration first

Each number opens the study's record on ClinicalTrials.gov.

Registered studies that match the filters, newest registration first, with the library tests each one names and the outcome list that names them.
StudyStartPhaseConditionsParticipantsLead sponsorStatusLibrary tests named, with the latest time point
NCT07897474Start2026PhaseObservationalConditionsSleep and sleep disordersParticipants100Lead sponsorOtherStatusNot yet recruitingLibrary tests named
  • Trail Making TestPrimary
  • Stroop Color-Word TestPrimary
  • Digit Span TestPrimary
  • Symbol CodingPrimary
  • Psychomotor Vigilance TaskPrimary
NCT07889466Start2025PhaseNot applicableConditionsSleep and sleep disorders, Pain and fatigueParticipants203Lead sponsorOtherStatusCompletedLibrary tests named
  • Psychomotor Vigilance TaskPrimary6 weeks
NCT07883031Start2025PhaseNot applicableConditionsObesity and diabetesParticipants25Lead sponsorOtherStatusCompletedLibrary tests named
  • Psychomotor Vigilance TaskPrimary6 weeks
  • Eriksen Flanker TaskPrimary6 weeks
  • Task Switching TestPrimary6 weeks
NCT07848659Start2026PhasePhase 1ConditionsSleep and sleep disordersParticipants12Lead sponsorIndustryStatusRecruitingLibrary tests named
  • Psychomotor Vigilance TaskPrimary4 days
NCT07846865Start2026PhasePhase 2/3ConditionsObesity and diabetes, Sleep and sleep disordersParticipants256Lead sponsorOtherStatusNot yet recruitingLibrary tests named
  • Psychomotor Vigilance TaskOther outcome12 months
  • Spatial Working MemoryOther outcome12 months
NCT07834944Start2026PhaseNot applicableConditionsOther conditionsParticipants66Lead sponsorOtherStatusNot yet recruitingLibrary tests named
  • Psychomotor Vigilance TaskPrimary2 weeks
NCT07830056Start2025PhasePhase 4ConditionsSleep and sleep disordersParticipants33Lead sponsorOtherStatusRecruitingLibrary tests named
  • N-Back TaskPrimary1 week
  • Go/No-Go TaskPrimary1 week
  • Psychomotor Vigilance TaskPrimary1 week
  • Task Switching TestPrimary1 week
  • Finger Tapping TaskPrimary1 week
  • Balloon RiskSecondary1 week
NCT07822048Start2026PhaseNot applicableConditionsAging, frailty and exerciseParticipants20Lead sponsorOtherStatusRecruitingLibrary tests named
  • Trail Making TestOther outcome3 days
  • Psychomotor Vigilance TaskOther outcome3 days
NCT07819565Start2026PhaseNot applicableConditionsAging, frailty and exerciseParticipants20Lead sponsorOtherStatusRecruitingLibrary tests named
  • Trail Making TestOther outcome3 days
  • Psychomotor Vigilance TaskOther outcome3 days
NCT07793045Start2026PhaseNot applicableConditionsADHDParticipants40Lead sponsorOtherStatusRecruitingLibrary tests named
  • Stroop Color-Word TestSecondary6 weeks
  • Psychomotor Vigilance TaskSecondary6 weeks
NCT07771790Start2026PhaseNot applicableConditionsOther conditionsParticipants20Lead sponsorOtherStatusRecruitingLibrary tests named
  • Trail Making TestPrimary
  • Psychomotor Vigilance TaskPrimary
  • Eriksen Flanker TaskPrimary
NCT07766343Start2026PhaseNot applicableConditionsSleep and sleep disordersParticipants760Lead sponsorOtherStatusNot yet recruitingLibrary tests named
  • Psychomotor Vigilance TaskSecondary9 weeks
NCT07761611Start2026PhaseNot applicableConditionsPain and fatigueParticipants118Lead sponsorOtherStatusNot yet recruitingLibrary tests named
  • Psychomotor Vigilance TaskPrimary3 weeks
  • Simple Reaction TimePrimary3 weeks
NCT07750925Start2026PhaseNot applicableConditionsDepression and bipolar disorder, Healthy volunteers, Anxiety, PTSD and OCDParticipants45Lead sponsorOtherStatusNot yet recruitingLibrary tests named
  • Psychomotor Vigilance TaskSecondary1 week
NCT07748429Start2027PhaseNot applicableConditionsOther conditionsParticipants80Lead sponsorOtherStatusNot yet recruitingLibrary tests named
  • Psychomotor Vigilance TaskPrimary
  • Eriksen Flanker TaskPrimary
  • Simple Reaction TimeSecondary
NCT07744581Start2026PhaseNot applicableConditionsSleep and sleep disordersParticipants25Lead sponsorOtherStatusActive, not recruitingLibrary tests named
  • Psychomotor Vigilance TaskSecondary2 weeks
NCT07742150Start2026PhaseNot applicableConditionsOther conditionsParticipants120Lead sponsorOtherStatusNot yet recruitingLibrary tests named
  • Stroop Color-Word TestSecondary
  • Psychomotor Vigilance TaskSecondary
  • Eriksen Flanker TaskSecondary
NCT07728240Start2026PhaseObservationalConditionsAging, frailty and exerciseParticipants100Lead sponsorOtherStatusRecruitingLibrary tests named
  • Psychomotor Vigilance TaskOther outcome
NCT07710755Start2026PhaseNot applicableConditionsPain and fatigueParticipants30Lead sponsorOtherStatusNot yet recruitingLibrary tests named
  • Psychomotor Vigilance TaskPrimarysame day
NCT07699848Start2026PhaseNot applicableConditionsOther conditionsParticipants35Lead sponsorOtherStatusRecruitingLibrary tests named
  • Stroop Color-Word TestPrimarysame day
  • Psychomotor Vigilance TaskPrimarysame day
NCT07695246Start2026PhaseNot applicableConditionsAging, frailty and exercise, Sleep and sleep disordersParticipants183Lead sponsorOtherStatusRecruitingLibrary tests named
  • N-Back TaskSecondary6 months
  • Card Sorting Test (Berg)Secondary6 months
  • Psychomotor Vigilance TaskSecondary6 months
  • Stop-Signal TaskSecondary6 months
NCT07684417Start2026PhaseNot applicableConditionsADHDParticipants50Lead sponsorOtherStatusRecruitingLibrary tests named
  • Psychomotor Vigilance TaskSecondary2 weeks
NCT07678918Start2026PhaseObservationalConditionsSleep and sleep disordersParticipants86Lead sponsorOtherStatusNot yet recruitingLibrary tests named
  • Psychomotor Vigilance TaskPrimary1 week
NCT07654777Start2026PhaseNot applicableConditionsAnxiety, PTSD and OCDParticipants52Lead sponsorOtherStatusRecruitingLibrary tests named
  • Go/No-Go TaskPrimary9 weeks
  • Psychomotor Vigilance TaskSecondary9 weeks
NCT07651917Start2026PhasePhase 4ConditionsOther conditionsParticipants50Lead sponsorOtherStatusNot yet recruitingLibrary tests named
  • Trail Making TestSecondarysame day
  • Stroop Color-Word TestSecondarysame day
  • Digit Span TestSecondarysame day
  • N-Back TaskSecondarysame day
  • Go/No-Go TaskSecondarysame day
  • Psychomotor Vigilance TaskPrimarysame day
  • Eriksen Flanker TaskSecondarysame day
  • Task Switching TestSecondarysame day
  • Corsi Block-Tapping TestSecondarysame day

Page 1 of 16

Questions, answered from the data

How many clinical trials use the Psychomotor Vigilance Task?

395 registered studies on ClinicalTrials.gov name it in an outcome measure, 154 of them in a primary outcome.

In which conditions do trials use the Psychomotor Vigilance Task?

Most often in sleep and sleep disorders (237), pain and fatigue (35) and healthy volunteers (31).

Do new trials use the Psychomotor Vigilance Task more or less?

2.2% of the studies that started in 2021 to 2025 name it, against 2.3% of those that started in 2016 to 2020: a share 3% smaller.

Which tests do trials use with the Psychomotor Vigilance Task?

Symbol Coding (52 studies), the N-Back Task (46 studies) and the Stroop Color-Word Test (34 studies).

How many participants do phase 2 trials that use the Psychomotor Vigilance Task enroll?

Half of the phase 2 studies that name it enroll 61 participants or fewer, and the middle half enroll 35 to 139. 34 of them give a size.

When do trials measure the Psychomotor Vigilance Task?

Half of the primary outcomes that name the Psychomotor Vigilance Task are measured within 2 weeks of the start, and the middle half from the first day to 6 weeks. 131 primary outcomes give a duration.

How many completed trials that use the Psychomotor Vigilance Task have reported results?

123 of the 225 completed studies that name it, 55%, have reported results: 54 posted them on ClinicalTrials.gov, 94 have a results paper linked to the registry record, and 25 did both. The other 102 show neither. Of all completed studies with a cognitive outcome, 46% have reported results.

More on tests in clinical trials

  • Psychomotor Vigilance Task: what it measures, its scores, and a version to try
  • All 101 tests in clinical trials
  • Cognitive tests by condition
  • Every registered study, by test, condition, phase and year

How the studies are counted

For each test family, the census runs ClinicalTrials.gov's own outcome search for the family's names and reads every study first posted by the day the family was counted. These studies were read on 10 November 2026. A study counts once on a page, however many tests it names. Counts for a test cover every version of the task under any of its names, so a page can count studies that used a commercial version.

The census adds two things to each record and changes nothing in it: which outcome list names the test (primary, then secondary, then other), and the condition groups, matched on the study's condition names and MeSH terms. A study can fall in several groups; one whose only condition is cognitive impairment or decline falls in “Cognitive impairment and decline”. Studies that name only instruments outside the library count in every total and share but are not listed.

A second read on 10 November 2026 added each study's overall status, whether results are posted, its intervention types, the countries of its sites and the time frame of the outcome that names each test. A time frame counts by the latest time point it names: “Baseline, 12 and 24 weeks” is 24 weeks, a single visit is within a day, and one that names no duration, such as “end of treatment”, is left out of the timings.

A third read on 10 November 2026 added the papers the registry links to each study: those its sponsor lists as reporting results, and those PubMed links to it through the study's NCT number. A study has a results paper when one of them came out in or after the month of its primary completion and PubMed does not class it as a protocol, review or comment. A paper that never gives the NCT number is not linked, so some studies counted as reporting neither did publish.

Source: ClinicalTrials.gov, a database of the U.S. National Library of Medicine, which does not endorse these pages. Every study line is in the data release 2.1.0, and the explorer's own file is clinical-trials-studies.json.

Run the Psychomotor Vigilance Task in your trial

Choose tests with a record in registered trials, and run them in a browser at every site, on the same version each visit.

Start free
ConductCognition

Hosted browser-native cognitive testing for academic and commercial research workflows.

A product of ConductScience, Inc.

New tests and features, about once a month. Unsubscribe at any time.

Tests

  • All cognitive tests
  • Test batteries
  • Use and evidence
  • Test norms
  • Trail Making Test
  • N-Back Task
  • Automated scoring
  • Study design
  • New tests by email

Guides

  • Methods and questions
  • Blog
  • Recruitment setup
  • Participant devices
  • Prolific
  • Sona Systems
  • CloudResearch Connect
  • Qualtrics

Use cases

  • Student participant pools
  • Aging and dementia research
  • Clinical trials
  • US clinical research
  • Remote testing

Compare and buy

  • Pricing
  • Compare platforms
  • Offline edition
  • FAQ

Trust

  • Study Quality Monitor
  • HIPAA-ready testing
  • Data export
  • Privacy Policy
  • Terms of Use
  • Data Policy

Company

  • ConductScience
  • Affiliate Program
© 2026 ConductScience, Inc. Research use only.